VANGUARD DA2Pi-CPV-Lepto lyophilisat et solvant pour suspension injectable
VANGUARD DA2Pi-CPV-Lepto lyophilisat et solvant pour suspension injectable
Authorised
- Canine parainfluenza virus, strain NL-CPI-5, Live
- Canine distemper virus, strain N-CDV, Live
- Canine adenovirus 2, strain Manhattan, Live
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
- Canine parvovirus, strain NL-35-D, Live
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
Product identification
Medicine name:
VANGUARD DA2Pi-CPV-Lepto lyophilisat et solvant pour suspension injectable
VANGUARD DA2Pi-CPV-Lepto lyofilisaat en oplosmiddel voor suspensie voor injectie
VANGUARD DA2Pi-CPV-Lepto Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension
Active substance:
- Canine parainfluenza virus, strain NL-CPI-5, Live
- Canine distemper virus, strain N-CDV, Live
- Canine adenovirus 2, strain Manhattan, Live
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
- Canine parvovirus, strain NL-35-D, Live
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine parainfluenza virus, strain NL-CPI-5, Live1000000.00cell culture infective dose 501.00millilitre(s)
-
Canine distemper virus, strain N-CDV, Live1000.00cell culture infective dose 501.00millilitre(s)
-
Canine adenovirus 2, strain Manhattan, Live1585.00cell culture infective dose 501.00millilitre(s)
-
Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated40.00Protective Dose1.00millilitre(s)
-
Canine parvovirus, strain NL-35-D, Live10000000.00cell culture infective dose 501.00millilitre(s)
-
Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated40.00Protective Dose1.00millilitre(s)
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AI02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V161621
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
How useful was this page?: